Amgen brings 6 presentations to BPI 2026 in Boston. Its program covers model-based cell culture control and downstream scale-up. Work includes data automation with model predictive control, a quality-by-design framework for critical material attribute risk in chemically defined media, and approaches to impurity removal in complex biologics.
| Organization | BPI 2026 Attendance |
|---|---|
Amgen Thousand Oaks, California | 1 Associate Scientist · 1 Senior Principal Scientist · 1 Senior Scientist, Process Development Downstream · 1 Senior Scientist · 1 other speaker |
Global biopharmaceutical company developing and manufacturing biologic medicines. | Talk Wed Sep 23 9:00am–9:30am Talk Wed Sep 23 11:15am–11:45am Panel Wed Sep 23 2:00pm–2:30pm Chair Thu Sep 24 11:25am–11:30am Panel Thu Sep 24 4:30pm–5:00pm Chair Fri Sep 25 8:50am–9:00am |
Instantly find 20 buyers from Amgen
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction